
Liquidity, historical trends, and peer comparisons.
According to Spruce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.23. This represents a change of 79.13% compared to the average of 5.15 of the last 4 quarters.
The mean historical Current Ratio of Spruce Biosciences, Inc. over the last ten years is 6.07. The current 9.23 Current Ratio has changed 51.90% with respect to the historical average. Over the past ten years (40 quarters), SPRB's Current Ratio was at its highest in in the March 2021 quarter at 22.13. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
6.07
Median
4.67
Minimum
1.08
Maximum
16.43
Discovering the peaks and valleys of Spruce Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.42%
Maximum Annual Current Ratio = 16.43
Minimum Annual Increase = -38.73%
Minimum Annual Current Ratio = 1.08
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.17 | 78.19% |
| 2024 | 2.90 | -30.58% |
| 2023 | 4.18 | -37.82% |
| 2022 | 6.72 | -35.16% |
| 2021 | 10.36 | -36.95% |
| 2020 | 16.43 | 1.42% |
| 2019 | 1.08 | -38.73% |
The current Current Ratio of Spruce Biosciences, Inc. (SPRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.08
5-year avg
5.86
10-year avg
6.07
Spruce Biosciences, Inc.’s Current Ratio is greater than NRx Pharmaceuticals, Inc. (0.86), greater than Werewolf Therapeutics, Inc. (2.91), greater than Outlook Therapeutics, Inc. (0.81), greater than IO Biotech, Inc. (2.01), greater than Cue Biopharma, Inc. (1.25), greater than OS Therapies Incorporated (0.18), less than vTv Therapeutics Inc. (12.48), less than Equillium, Inc. (23.40), greater than Coeptis Therapeutics Holdings, Inc. (7.66),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.86 | $94.60M | |
| 2.91 | $50.06M | |
| 0.81 | $112.76M | |
| 2.01 | $885.69K | |
| 1.25 | $143.47M | |
| 0.18 | $55.46M | |
| 12.48 | $95.09M | |
| 23.40 | $87.50M | |
| 7.66 | $38.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spruce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spruce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Spruce Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Spruce Biosciences, Inc. (SPRB)?
What is the highest Current Ratio for Spruce Biosciences, Inc. (SPRB)?
What is the 3-year average Current Ratio for Spruce Biosciences, Inc. (SPRB)?
What is the 5-year average Current Ratio for Spruce Biosciences, Inc. (SPRB)?
How does the current Current Ratio for Spruce Biosciences, Inc. (SPRB) compare to its historical average?